Federated Hermes, Inc. Fusion Pharmaceuticals Inc. Transaction History

Federated Hermes, Inc.

$42.5 Billion
Q1 2024

A detailed history of Federated Hermes, Inc. transactions in Fusion Pharmaceuticals Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 10,811,153 shares of FUSN stock, worth $0. This represents 0.54% of its overall portfolio holdings.

Number of Shares

10,811,153

Previous 10,886,153 0.69%

Holding current value

Previous $105 Million 120.33%

% of portfolio

0.54%

Previous 0.26%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$7.9 - $21.32 $592,500 - $1.6 Million	-75,000 Reduced 0.69%	10,811,153 $230 Million
Q4 2023 Jan 31, 2024	BUY	$2.48 - $9.65 $501,862 - $1.95 Million	202,364 Added 1.89%	10,886,153 $105 Million
Q3 2023 Nov 13, 2023	BUY	$2.37 - $4.63 $118,500 - $231,500	50,000 Added 0.47%	10,683,789 $27.8 Million
Q2 2023 Aug 14, 2023	BUY	$3.47 - $5.33 $16.6 Million - $25.5 Million	4,784,689 Added 81.8%	10,633,789 $49.7 Million
Q1 2023 May 08, 2023	BUY	$3.03 - $5.13 $7.95 Million - $13.5 Million	2,625,000 Added 81.42%	5,849,100 $22.1 Million

Q4 2022 Feb 13, 2023	BUY	$2.1 - $3.34 $105,000 - $167,000	50,000 Added 1.58%	3,224,100 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$2.0 - $3.56 $100,000 - $178,000	50,000 Added 1.6%	3,174,100 $9.56 Million
Q2 2022 Aug 15, 2022	BUY	$2.49 - $7.86 $171,966 - $542,835	69,063 Added 2.26%	3,124,100 $7.78 Million
Q1 2022 May 13, 2022	BUY	$4.53 - $8.57 $6.71 Million - $12.7 Million	1,481,037 Added 94.09%	3,055,037 $23.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.17 - $7.78 $500,858 - $934,455	120,110 Added 8.26%	1,574,000 $6.56 Million
Q3 2021 Nov 15, 2021	BUY	$7.83 - $9.41 $6.7 Million - $8.06 Million	856,049 Added 143.19%	1,453,890 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $261,742 - $350,085	32,841 Added 5.81%	597,841 $4.83 Million
Q1 2021 May 13, 2021	BUY	$9.75 - $13.09 $390,000 - $523,600	40,000 Added 7.62%	565,000 $6.06 Million
Q4 2020 Feb 12, 2021	BUY	$11.5 - $13.73 $172,500 - $205,950	15,000 Added 2.94%	525,000 $6.17 Million
Q3 2020 Nov 12, 2020	BUY	$11.8 - $17.1 $2.24 Million - $3.25 Million	190,000 Added 59.38%	510,000 $6.13 Million
Q2 2020 Aug 13, 2020	BUY	$17.0 - $17.78 $5.44 Million - $5.69 Million	320,000 New	320,000 $5.59 Million

Others Institutions Holding FUSN

# of Institutions

142

Shares Held

67.3M

Call Options Held

1.36M

Put Options Held

3.97M

View Full List

About Fusion Pharmaceuticals Inc.

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

More about FUSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Fusion Pharmaceuticals Inc. Transaction History